FBW7 mutations mediate resistance of colorectal cancer to targeted therapies by blocking Mcl-1 degradation
出版年份 2016 全文链接
标题
FBW7 mutations mediate resistance of colorectal cancer to targeted therapies by blocking Mcl-1 degradation
作者
关键词
-
出版物
ONCOGENE
Volume 36, Issue 6, Pages 787-796
出版商
Springer Nature
发表日期
2016-07-11
DOI
10.1038/onc.2016.247
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mitochondria—Judges and Executioners of Cell Death Sentences
- (2016) Patrick D. Bhola et al. MOLECULAR CELL
- The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics
- (2015) A. N. Hata et al. Cancer Discovery
- Cyclin E/Cdk2-dependent phosphorylation of Mcl-1 determines its stability and cellular sensitivity to BH3 mimetics
- (2015) Gaurav S. Choudhary et al. Oncotarget
- TAp73 promotes cell survival upon genotoxic stress by inhibiting p53 activity
- (2015) Dongshi Chen et al. Oncotarget
- Tumor Suppression by the Fbw7 Ubiquitin Ligase: Mechanisms and Opportunities
- (2014) Ryan J. Davis et al. CANCER CELL
- Regorafenib Inhibits Colorectal Tumor Growth through PUMA-Mediated Apoptosis
- (2014) D. Chen et al. CLINICAL CANCER RESEARCH
- An update on the safety and efficacy of regorafenib in the treatment of solid cancers
- (2014) Stephen L Chan et al. Expert Opinion on Drug Metabolism & Toxicology
- Regulated protein turnover: snapshots of the proteasome in action
- (2014) Sucharita Bhattacharyya et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Dual Regulation of Fbw7 Function and Oncogenic Transformation by Usp28
- (2014) Christina Schülein-Völk et al. Cell Reports
- Mcl-1 Ubiquitination: Unique Regulation of an Essential Survival Protein
- (2014) Barbara Mojsa et al. Cells
- Targeting Bax interaction sites reveals that only homo-oligomerization sites are essential for its activation
- (2013) R Peng et al. CELL DEATH AND DIFFERENTIATION
- Evaluation and critical assessment of putative MCL-1 inhibitors
- (2013) S Varadarajan et al. CELL DEATH AND DIFFERENTIATION
- Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
- (2012) George D Demetri et al. LANCET
- Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
- (2012) Axel Grothey et al. LANCET
- Negative Regulation of the Stability and Tumor Suppressor Function of Fbw7 by the Pin1 Prolyl Isomerase
- (2012) Sang-Hyun Min et al. MOLECULAR CELL
- Inhibiting oncogenic signaling by sorafenib activates PUMA via GSK3β and NF-κB to suppress tumor cell growth
- (2012) C Dudgeon et al. ONCOGENE
- Mcl-1 and FBW7 Control a Dominant Survival Pathway Underlying HDAC and Bcl-2 Inhibitor Synergy in Squamous Cell Carcinoma
- (2012) Lei He et al. Cancer Discovery
- MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression
- (2011) Mikael Lerner et al. CELL CYCLE
- An Update on the Current and Emerging Targeted Agents in Metastatic Colorectal Cancer
- (2011) Edward Chu Clinical Colorectal Cancer
- SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction
- (2011) Hiroyuki Inuzuka et al. NATURE
- Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
- (2011) Ingrid E. Wertz et al. NATURE
- The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis
- (2010) Kuppusamy Balamurugan et al. EMBO JOURNAL
- Mcl-1; the molecular regulation of protein function
- (2010) Luke W. Thomas et al. FEBS LETTERS
- Regorafenib (BAY 73-4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
- (2010) Scott M. Wilhelm et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer
- (2010) Alberto Bardelli et al. JOURNAL OF CLINICAL ONCOLOGY
- Colorectal cancer
- (2010) David Cunningham et al. LANCET
- Chemoprevention by nonsteroidal anti-inflammatory drugs eliminates oncogenic intestinal stem cells via SMAC-dependent apoptosis
- (2010) W. Qiu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RING Domain E3 Ubiquitin Ligases
- (2009) Raymond J. Deshaies et al. Annual Review of Biochemistry
- American Society of Clinical Oncology Provisional Clinical Opinion: Testing forKRASGene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Therapy
- (2009) Carmen J. Allegra et al. JOURNAL OF CLINICAL ONCOLOGY
- Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival
- (2009) Martin Schwickart et al. NATURE
- Molecular Basis of Colorectal Cancer
- (2009) Sanford D. Markowitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started